Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 4.050
+0.970 (31.49%)
At close: Mar 10, 2026
Kintor Pharmaceutical Revenue
Kintor Pharmaceutical had revenue of 5.98M CNY in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 10.98M. In the year 2024, Kintor Pharmaceutical had annual revenue of 5.00M.
Revenue (ttm)
10.98M CNY
Revenue Growth
n/a
P/S Ratio
126.29
Revenue / Employee
80.76K CNY
Employees
136
Market Cap
1.52B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mabpharm | 464.53M |
| Cutia Therapeutics | 274.31M |
| Beijing Biostar Pharmaceuticals | 58.66M |
| CANbridge Pharmaceuticals | 68.55M |
| Zhaoke Ophthalmology | 38.74M |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.43B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 134.60M |
| Wuhan YZY Biopharma | 163.65M |